share_log

港股异动 | 医脉通(02192)绩后涨超6% 经调整净溢利同比增超三成 净利润率继续保持较高水平

HKEX unusual movement | Medlinker (02192) rose more than 6% after the performance adjustment, with a year-on-year increase of more than 30% in net income and a continued high net profit margin.

Zhitong Finance ·  Aug 28 10:31

After the performance, Yitong (02192) rose more than 6%, and as of the time of publication, it rose 6.52%, to 8.13 Hong Kong dollars, with a turnover of 7.139 million Hong Kong dollars.

According to Zhitong Financial APP, Yitong (02192) rose more than 6% after the performance, and as of the time of publication, it rose 6.52%, to 8.13 Hong Kong dollars, with a turnover of 7.139 million Hong Kong dollars.

In terms of news, Yitong has released its interim performance for the six months ended June 30, 2024. The group achieved an income of 0.243 billion yuan (unit as above), an increase of 40.3% year-on-year. The attributable surplus of the parent company amounted to 0.147 billion yuan, an increase of 48.6% year-on-year. The adjusted net surplus under non-Hong Kong financial reporting standards amounted to 0.156 billion yuan, an increase of 30.3% year-on-year. The basic earnings per share were 20.18 cents, and a mid-term dividend of 12.05 cents per share is proposed.

The announcement stated that the group's net profit margin continued to maintain a relatively high level, increasing by 4.1 percentage points from approximately 58.6% for the six months ended June 30, 2023 to approximately 62.7% for the six months ended June 30, 2024. The adjusted net profit and adjusted net profit margin for the six months ended June 30, 2024 were 0.156 billion yuan and 64.1% respectively, continuing to maintain a leading position in the industry.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment